BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/30/2016 5:59:00 PM | Browse: 1415 | Download: 2800
 |
Received |
|
2016-06-02 09:15 |
|
Peer-Review Started |
|
2016-06-02 10:09 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2016-07-15 15:29 |
|
Revised |
|
2016-07-27 13:12 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2016-08-17 09:35 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2016-08-23 17:20 |
|
Articles in Press |
|
2016-08-23 17:20 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-09-09 17:38 |
|
Publish the Manuscript Online |
|
2016-09-30 18:06 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Ryul Kim, Bhumsuk Keam, Dohee Kwon, Chan-Young Ock, Miso Kim, Tae Min Kim, Hak Jae Kim, Yoon Kyung Jeon, In Kyu Park, Chang Hyun Kang, Dong-Wan Kim, Young Tae Kim and Dae Seog Heo |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Seoul National University Hospital Research Fund |
03-2015-0380 |
| Ministry of Health and Welfare, South Korea |
HI06C0874 |
|
| Corresponding Author |
Bhumsuk Keam, MD, PhD, Clinical Associate Professor, Department of Internal Medicine, Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, South Korea. bhumsuk@snu.ac.kr
|
| Key Words |
Esophageal neoplasm; Programmed death ligand-1 protein; c-Met protein; Prognosis; p16INK4A protein |
| Core Tip |
The clinical significance of expression of programmed death ligand-1 (PD-L1) in esophageal squamous cell carcinoma (ESCC) has not yet been fully established. We analyzed tissue microarrays of surgical specimen of 200 ESCC patients by immunohistochemistry with antibodies directed against PD-L1, p16, and c-Met. Our results suggest that tumors from approximately one-third of the ESCC patients are positive for PD-L1 expression, and PD-L1 expression is positively correlated with c-Met expression. Although PD-L1 positivity was not found to be associated with survival of ESCC patients, we show that it may play a critical role in distant failure and progression of ESCC.
|
| Publish Date |
2016-09-30 18:06 |
| Citation |
Kim R, Keam B, Kwon D, Ock CY, Kim M, Kim TM, Kim HJ, Jeon YK, Park IK, Kang CH, Kim DW, Kim YT, Heo DS. Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma. World J Gastroenterol 2016; 22(37): 8389-8397
|
| URL |
http://www.wjgnet.com/1007-9327/full/v22/i37/8389.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v22.i37.8389 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
